Mithra Pharmaceuticals SA reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was EUR 40.16 million compared to EUR 67 million a year ago. Net loss was EUR 173.5 million compared to EUR 59.62 million a year ago.
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
0.216 EUR | -1.82% | -.--% | -82.78% |
Apr. 29 | Mithra Pharmaceuticals to Postpone the Publication of Its Annual Report 2023 | CI |
Apr. 22 | Mithra Pharmaceuticals Obtains Court Protection Measures | MT |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-82.78% | 16.08M | |
-2.35% | 89.08B | |
+3.55% | 40.9B | |
-14.40% | 32.25B | |
+54.44% | 25.14B | |
-15.96% | 15.39B | |
-15.50% | 11.91B | |
-41.29% | 11.89B | |
-11.75% | 11.64B | |
+6.44% | 9.03B |
- Stock Market
- Equities
- MITRA Stock
- News Mithra Pharmaceuticals S.A.
- Mithra Pharmaceuticals SA Reports Earnings Results for the Full Year Ended December 31, 2023